Extensive MHC class I-restricted CD8 T lymphocyte responses against various yeast genera in humans

FEMS Immunology and Medical Microbiology

Volumn 39, Issue 3, 2003, Pages 279-286

  Heintel, Tanja ^a   Breinig, Frank ^a   Schmitt, Manfred J ^a   Meyerhans, Andreas ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cellular activation; Fungal infection; Human; T lymphocyte

Indexed keywords

CD69 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FUNGUS ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE ANTIGEN;

ADULT; ARTICLE; BLOOD; CELL STIMULATION; CELL WALL; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; MEMORY CELL; METABOLISM; MICROBIOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; YEAST;

EID: 0344585352     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00294-3     Document Type: Article

References (49)

1. Murphy J.W. Immunological down-regulation of host defenses in fungal infections. Mycoses. 42:1999;37-43.
2. Jarvis W.R. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1995;1526-1530.
3. Monari C., Casadevall A., Baldelli F., Francisci D., Pietrella D., Bistoni F., Vecchiarelli A. Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy. AIDS. 14:2000;2699-2708.
4. Brawner D.L., Cutler J.E. Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J. Clin. Microbiol. 27:1989;1335-1341.
5. Miller M.F., Mitchell T.G. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59:1991;24-28.
6. Clemons K.V., Calich V.L., Burger E., Filler S.G., Grazziutti M., Murphy J., Roilides E., Campa A., Dias M.R., Edwards J.E. Jr., Fu Y., Fernandes-Bordignon G., Ibrahim A., Katsifa H., Lamaignere C.G., Meloni-Bruneri L.H., Rex J., Savary C.A., Xidieh C. Pathogenesis I: interactions of host cells and fungi. Med. Mycol. 38:2000;99-111.
7. Vecchiarelli A., Monari C., Baldelli F., Pietrella D., Retini C., Tascini C., Francisci D., Bistoni F. Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS. J. Infect. Dis. 171:1995;1448-1454.
8. Heimdahl A., Nord C.E. Oral yeast infections in immunocompromised and seriously diseased patients. Acta Odontol. Scand. 48:1990;77-84.
9. Yuan R.R., Spira G., Oh J., Paizi M., Casadevall A., Scharff M.D. Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect. Immun. 66:1998;1057-1062.
10. Mukherjee J., Nussbaum G., Scharff M.D., Casadevall A. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181:1995;405-409.
11. Levitz S.M. Overview of host defenses in fungal infections. Clin. Infect. Dis. 14:(Suppl. 1):1992;S37-S42.
12. Romani L., Howard D.H. Mechanisms of resistance to fungal infections. Curr. Opin. Immunol. 7:1995;517-523.
13. Romani L., Puccetti P., Bistoni F. Biological role of Th cell subsets in candidiasis. Chem. Immunol. 63:1996;115-137.
14. Decken K., Kohler G., Palmer-Lehmann K., Wunderlin A., Mattner F., Magram J., Gately M.K., Alber G. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 66:1998;4994-5000.
15. Heintel T., Sester M., Rodriguez M.M., Krieg C., Sester U., Wagner R., Pees H.W., Gartner B., Maier R., Meyerhans A. The fraction of perforin-expressing HIV-specific CD8 T cells is a marker for disease progression in HIV infection. AIDS. 16:2002;1497-1501.
16. Sester M., Sester U., Kohler H., Schneider T., Deml L., Wagner R., Mueller-Lantzsch N., Pees H.W., Meyerhans A. Rapid whole blood analysis of virus-specific CD4 and CD8 T cell responses in persistent HIV infection. AIDS. 14:2000;2653-2660.
17. Sester M., Sester U., Gartner B., Heine G., Girndt M., Mueller-Lantzsch N., Meyerhans A., Kohler H. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation. 71:2001;1287-1294.
18. Suni M.A., Picker L.J., Maino V.C. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J. Immunol. Methods. 212:1998;89-98.
19. Waldrop S.L., Pitcher C.J., Peterson D.M., Maino V.C., Picker L.J. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99:1997;1739-1750.
20. Zimmermann C., Prevost-Blondel A., Blaser C., Pircher H. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur. J. Immunol. 29:1999;284-290.
21. Champagne P., Ogg G.S., King A.S., Knabenhans C., Ellefsen K., Nobile M., Appay V., Rizzardi G.P., Fleury S., Lipp M., Forster R., Rowland-Jones S., Sekaly R.P., McMichael A.J., Pantaleo G. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 410:2001;106-111.
22. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:1999;708-712.
23. Breinig F., Tipper D.J., Schmitt M.J. Kre1p, the plasma membrane receptor for the yeast K1 viral toxin. Cell. 108:2002;395-405.
24. Schmitt M.J., Tipper D.J. K28, a unique double-stranded RNA killer virus of Saccharomyces cerevisiae. Mol. Cell. Biol. 10:1990;4807-4815.
25. Edwards J.E. Jr. Invasive Candida infections-evolution of a fungal pathogen. N. Engl. J. Med. 324:1991;1060-1062.
26. Fradin C., Kretschmar M., Nichterlein T., Gaillardin C., d'Enfert C., Hube B. Stage-specific gene expression of Candida albicans in human blood. Mol. Microbiol. 47:2003;1523-1543.
27. Kobayashi S.D., Cutler J.E. Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol. 6:1998;92-94.
28. Bassilana M., Blyth J., Arkowitz R.A. Cdc24, the GDP-GTP exchange factor for Cdc42, is required for invasive hyphal growth of Candida albicans. Eukaryot. Cell. 2:2003;9-18.
29. Breinig F., Heintel T., Schumacher A., Meyerhans A., Schmitt M.J. Specific activation of CMV-primed human T lymphocytes by cytomegalovirus pp65 expressed in fission yeast. FEMS Immunol. Med. Microbiol. 38:2003;231-239.
30. La Valle R., Sandini S., Gomez M.J., Mondello F., Romagnoli G., Nisini R., Cassone A. Generation of a recombinant 65-kilodalton mannoprotein, a major antigen target of cell-mediated immune response to Candida albicans. Infect. Immun. 68:2000;6777-6784.
31. Levitz S.M., Nong S., Mansour M.K., Huang C., Specht C.A. Molecular characterization of a mannoprotein with homology to chitin deacetylases that stimulates T cell responses to Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA. 98:2001;10422-10427.
32. San-Blas G., Travassos L.R., Fries B.C., Goldman D.L., Casadevall A., Carmona A.K., Barros T.F., Puccia R., Hostetter M.K., Shanks S.G., Copping V.M., Knox Y., Gow N.A. Fungal morphogenesis and virulence. Med. Mycol. 38:2000;79-86.
33. d'Ostiani C.F., Del Sero G., Bacci A., Montagnoli C., Spreca A., Mencacci A., Ricciardi-Castagnoli P., Romani L. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J. Exp. Med. 191:2000;1661-1674.
34. Ehl S., Klenerman P., Aichele P., Hengartner H., Zinkernagel R.M. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro. Eur. J. Immunol. 27:1997;3404-3413.
35. Smits G.J., Kapteyn J.C., van den Ende H., Klis F.M. Cell wall dynamics in yeast. Curr. Opin. Microbiol. 2:1999;348-352.
36. Pietrella D., Cherniak R., Strappini C., Perito S., Mosci P., Bistoni F., Vecchiarelli A. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect. Immun. 69:2001;2808-2814.
37. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 19:1998;395-404.
38. Wain-Hobson S., Meyerhans A. On viral epidemics, zoonoses and memory. Trends Microbiol. 7:1999;389-391.
39. Lavoie P.M., Thibodeau J., Erard F., Sekaly R.P. Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol. Rev. 168:1999;257-269.
40. McMichael A., Hanke T. The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible? Nat. Rev. Immunol. 2:2002;283-291.
41. Robinson H.L. New hope for an AIDS vaccine. Nat. Rev. Immunol. 2:2002;239-250.
42. Ward S., Lauer G., Isba R., Walker B., Klenerman P. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin. Exp. Immunol. 128:2002;195-203.
43. Prince A.M. Perspectives on prophylactic and therapeutic immunization against hepatitis B and C viruses. Transfus. Clin. Biol. 8:2001;467-470.
44. Gellissen G., Melber K., Janowicz Z.A., Dahlems U.M., Weydemann U., Piontek M., Strasser A.W., Hollenberg C.P. Heterologous protein production in yeast. Antonie van Leeuwenhoek. 62:1992;79-93.
45. Eckart M.R., Bussineau C.M. Quality and authenticity of heterologous proteins synthesized in yeast. Curr. Opin. Biotechnol. 7:1996;525-530.
46. Rios-Hernandez M., Dos-Santos N.J., Silvia C., Bello-Garciga J.L., Pedroso M. Immunopharmacological studies of beta-1,3-glucan. Arch. Med. Res. 25:1994;179-180.
47. Toda S., Ishii N., Okada E., Kusakabe K.I., Arai H., Hamajima K., Gorai I., Nishioka K., Okuda K. HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody. Immunology. 92:1997;111-117.
48. Shibata Y., Metzger W.J., Myrvik Q.N. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol. 159:1997;2462-2467.
49. Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., Franzusoff A., Duke R.C., Wilson C.C. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat. Med. 7:2001;625-629.